Caroline Corbel

发表

Tamoxifen inhibits CDK5 kinase activity by interacting with p35/p25 and modulates the pattern of tau phosphorylation.

K. Kosik, I. Landrieu, P. Colas, 2015, Chemistry & biology.

Identification of potential cellular targets of aloisine A by affinity chromatography.

L. Meijer, O. Lozach, J. Lemoine, 2009, Bioorganic & medicinal chemistry.

Tamoxifen Inhibits CDK 5 Kinase Activity by Interacting with p 35 / p 25 and Modulates the Pattern of Tau Phosphorylation Graphical

K. Kosik, I. Landrieu, P. Colas, 2015 .

First BRET-based screening assay performed in budding yeast leads to the discovery of CDK5/p25 interaction inhibitors.

V. Tan, P. Colas, O. Lozach, 2011, Biotechnology journal.

Developmental attenuation of N-methyl-D-aspartate receptor subunit expression by microRNAs

K. Kosik, I. Hernandez, Bian Wu, 2015, Neural Development.

An in silico approach for the discovery of CDK5/p25 interaction inhibitors.

Vincent B. C. Tan, Bing Zhang, Françoise Guéritte, 2011, Biotechnology journal.

The BRET technology and its application to screening assays

Cyril Couturier, R. Jockers, C. Couturier, 2008, Biotechnology journal.

Screening for Protein-Protein Interaction Inhibitors Using a Bioluminescence Resonance Energy Transfer (BRET)–Based Assay in Yeast

B. Montanini, P. Colas, E. Levati, 2017, SLAS discovery : advancing life sciences R & D.

Identification of Novel Compounds Inhibiting the Kinase Activity of the CDK5/p25 Complex via Direct Binding to p25.

P. Loyer, A. Le Grand, O. Sire, 2023, Biochemistry.

First BRET-based screening assay performed in budding yeast leads to the discovery of CDK5/p25 interaction inhibitors.

V. Tan, P. Colas, O. Lozach, 2011, Biotechnology Journal.